Advertisement

Topic - Oxycontin

Related Stories

Tanny Austin cries while looking at tombstones with the names of victims of the opioid crisis, including her son Sean Austin, during a rally outside of a courthouse in Newark, N.J., Tuesday, April 21, 2026. (AP Photo/Seth Wenig)

OxyContin maker Purdue Pharma’s settlement, by the numbers

By Geoff Mulvihill - Associated Press

People rally outside a courthouse while a hearing for Purdue Pharma takes place inside in Newark, N.J., Tuesday, April 21, 2026. (AP Photo/Seth Wenig)

OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence

By Geoff Mulvihill - Associated Press

FILE - Protesters who have lost love ones to the opioid crisis protest outside a courthouse in Boston, Aug. 2, 2019, where a judge heard arguments in a lawsuit against Purdue Pharma. (AP Photo/Charles Krupa, File)

Judge postpones OxyContin-maker Purdue Pharma’s sentencing to let opioid victims attend in person

By Geoff Mulvihill - Associated Press

FILE - "Pill Man" made by Frank Huntley of Worcester, Mass., from his opioid prescription pill bottles, is displayed during a protest by advocates for opioid victims outside the Department of Justice, Dec. 3, 2021, in Washington. (AP Photo/Carolyn Kaster, File)

Here’s what’s in the opioid settlement against OxyContin maker Purdue, Sackler family

By GEOFF MULVIHILL - Associated Press

FILE - "Pill Man" made by Frank Huntley of Worcester, Mass., from his opioid prescription pill bottles, is displayed during a protest by advocates for opioid victims outside the Department of Justice, Dec. 3, 2021, in Washington. (AP Photo/Carolyn Kaster, File)

Judge approves opioid settlement for Purdue Pharma and Sackler family members who own the company

By Geoff Mulvihill - Associated Press

Kathleen Scarpone, of Kingston, N.H., protests in front of the Arthur M. Sackler Museum at Harvard University, Friday, April 12, 2019, in Cambridge, Mass. (AP Photo/Josh Reynolds)

Harvard University rebuffs protests and won’t remove Sackler name from two buildings

By Michael Casey - Associated Press

Kathleen Scarpone, of Kingston, N.H., protests in front of the Arthur M. Sackler Museum at Harvard University, Friday, April 12, 2019, in Cambridge, Mass. (AP Photo/Josh Reynolds)

Harvard rebuffs protests and won’t remove Sackler name from two buildings

By Michael Casey - Associated Press

In this Feb. 19, 2013 file photo, OxyContin pills are arranged for a photo at a pharmacy in Montpelier, Vt. Companies and U.S. government entities have agreed to settlements of lawsuits over the toll of opioids totaling more than $50 billion. (AP Photo/Toby Talbot, File)

OxyContin marketer agrees to pay $350M rather than face lawsuits

Associated Press

The U.S. Supreme Court is seen before sunrise on Capitol Hill in Washington, March. 21, 2022. On Dec. 4, 2023, the Supreme Court will hear arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.(AP Photo/Jose Luis Magana) **FILE**

Supreme Court struggles with feds’ objection to Purdue Pharma bankruptcy deal

By Alex Swoyer - The Washington Times

Lynn Wencus, of Wrentham, Mass., holds a photograph of her son Jeff while seated in a garden at her home, in Wrentham, Tuesday, Nov. 7, 2023. Wencus lost Jeff to a heroin overdose in 2017. Families who lost loved ones to overdose are divided over OxyContin maker Purdue Pharma's plan to settle lawsuits over the toll of opioids with governments. It could provide billions to address an overdose epidemic and pay some victims. But it would also protect members of the Sackler family who own the company from future lawsuits. (AP Photo/Steven Senne)

OxyContin maker’s settlement plan divides victims of opioid crisis. Now it’s up to the Supreme Court

By Geoff Mulvihill and Mark Sherman - Associated Press

Court says OxyContin maker’s bankruptcy and protections for Sackler family members can move ahead

By Geoff Mulvihill - Associated Press

OxyContin pills are arranged for a photo at a pharmacy in Montpelier, Vt., Feb. 19, 2013. (AP Photo/Toby Talbot, File)

Frustration grows over wait on OxyContin maker’s settlement

By Geoff Mulvihill - Associated Press

Ohio Republican candidate for U.S. Senate, JD Vance, takes the stage to speak at the Conservative Political Action Conference (CPAC) in Dallas, Aug. 5, 2022. Vance founded a new charity called &quot;Our Ohio Renewal&quot; a day after the 2016 presidential election, promising to use it to help solve the scourge of opioid addiction, Vance's Senate rival, Democratic U.S. Rep. Tim Ryan, has targeted &quot;Our Ohio Renewal&quot; as a failure. (AP Photo/LM Otero, File)

Vance’s anti-drug charity enlisted doctor echoing Big Pharma

By Julie Carr Smyth - Associated Press

Lynn Wencus of Wrentham, Mass., holds a sign for her son Jeff along with wearing a sign showing loved ones lost to OxyContin and Opioid overdoses, during a protest at Purdue Pharma headquarters in Stamford, Conn., Friday, Aug. 17, 2018. Wencus lost her son Jeff to a heroin overdose in 2017. OxyContin maker Purdue Pharma and virtually all U.S. states have agreed to a new settlement of opioid lawsuits. The deal reached Thursday, March 3, 2022, would require members of the Sackler family who own the drugmaker to pay $5.5 billion to $6 billion in cash. They also apologized. A bankruptcy judge must still approve the deal. (AP Photo/Jessica Hill, File)

Purdue Pharma deal has families deflated, angry but hopeful

By John Seewer and Dave Collins - Associated Press

Fake pill bottles with messages about OxyContin maker Purdue Pharma are displayed during a protest outside the courthouse where the bankruptcy of the company is taking place in White Plains, N.Y., on Aug. 9, 2021. A judge said he is extending legal protections for members of the Sackler family, Wednesday, March 2, 2022, who own OxyContin maker Purdue Pharma by another three weeks to buy time to work out a new settlement to thousands of lawsuits over the opioid crisis. (AP Photo/Seth Wenig, File)

Purdue Pharma, U.S. states agree to new opioid settlement

By Geoff Mulvihill and John Seewer - Associated Press